How ARPA-H is developing FDA-authorized AI agents, tested in clinical trials

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. 

I found this poem, called “Questionnaire,” extremely timely, even though it was written more than 15 years ago.

The whole thing is worth reading and thinking about — may I suggest thinking about its implications for health care and biopharma while at STAT’s Breakthrough Summit East tomorrow? Hear from Chris Klomp, Rob Califf, Jane Grogan, and more. As a STAT+ subscriber, you get 40% off an in-person or virtual ticket.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In